cells Article Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity 1, 1, 2 1 Anupriya Chatterjee y, Rachana Eshwaran y, Gernot Poschet , Santosh Lomada , Mahmoud Halawa 1, Kerstin Wilhelm 3, Martina Schmidt 4,5 , Hans-Peter Hammes 6, Thomas Wieland 1,7 and Yuxi Feng 1,* 1 Experimental Pharmacology Mannheim, European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany;
[email protected] (A.C.);
[email protected] (R.E.);
[email protected] (S.L.);
[email protected] (M.H.);
[email protected] (T.W.) 2 Centre for Organismal Studies (COS), 69120 Heidelberg, Germany;
[email protected] 3 Angiogenesis & Metabolism Laboratory, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany;
[email protected] 4 Department of Molecular Pharmacology, University of Groningen, 9713 AV Groningen, The Netherlands;
[email protected] 5 Groningen Research Institute for Asthma and COPD, GRIAC, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands 6 5th Medical Clinic, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany;
[email protected] 7 DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Germany * Correspondence:
[email protected]; Tel.: +49-621-383-71762; Fax: +49-621-383-71750 These authors contributed equally. y Received: 27 August 2020; Accepted: 13 October 2020; Published: 19 October 2020 Abstract: Our previous studies identified that retinal endothelial damage caused by hyperglycemia or nucleoside diphosphate kinase-B (NDPK-B) deficiency is linked to elevation of angiopoietin-2 (Ang-2) and the activation of the hexosamine biosynthesis pathway (HBP).